New heart disease drug to be made available for NHS patients – GOV.UK

Up to 30,000 lives could be saved over the next decade thanks to a proposed pioneering government collaboration with pharmaceutical company Novartis to tackle heart disease – a leading cause of death in the UK.

The yet to be approved drug inclisiran, a treatment to lower cholesterol, will be studied in UK patients as part of a large-scale NHS clinical trial expected to start later this year. Additionally in a world-first, the drug is expected to be available through a population-level agreement – pioneering a game-changing approach to reducing the risk of heart disease.

Click here to read full article https://www.gov.uk/government/news/new-heart-disease-drug-to-be-made-available-for-nhs-patients

Share

Leave a Reply

Your email address will not be published. Required fields are marked *

Font Resize